Brookfield, CT
Politics
COVID-19: Here's How Much Longer Lamont Wants Executive Powers Extended COVID-19: Here's How Much Longer Lamont Wants Executive Powers Extended
Covid-19: Here's How Much Longer Lamont Wants Executive Powers Extended Connecticut Gov. Ned Lamont said that he expects to extend his emergency powers for another 90 days as he works with state lawmakers on certain COVID-19 mandates and protocols. With his emergency powers to expire on Thursday, Sept. 30, Lamont said he plans to extend his emergency powers 90 days further, saying that action through the General Assembly “takes too long.” The emergency powers would then be extended through Wednesday, Dec. 29. Lamont previously said that in order to continue issuing COVID-19-related executive orders, he would have to extend his emergency powers past Sept. 30. …

SHARE

by Zak Failla
Brookfield, CT
News
COVID-19: CT Has Plan In Place For Booster Shots, Lamont Says COVID-19: CT Has Plan In Place For Booster Shots, Lamont Says
Covid-19: CT Has Plan In Place For Booster Shots, Lamont Says Connecticut is ready to begin administering COVID-19 booster shots to residents across the state when they become eligible next month, Gov. Ned Lamont announced. This week, federal health officials announced that beginning the week of Monday, Sept. 20, third booster COVID-19 vaccine shots will be available to the public, citing concerns that the efficacy of Pfizer and Moderna vaccinations wanes after approximately eight months. Earlier story - COVID-19: CDC Announces Starting Date For Booster Shots In response, Lamont proclaimed that Connecticut - which had one of the most effective initia…

SHARE

by Zak Failla
Chappaqua, NY
News
COVID-19: CDC Announces Starting Date For Booster Shots COVID-19: CDC Announces Starting Date For Booster Shots
Covid-19: CDC Announces Starting Date For Booster Shots Federal health officials have set a date for when they plan to begin rolling out COVID-19 booster shots to help curtail the spread of new variants of the virus. Citing new data that showed Pfizer and Moderna vaccines’ effectiveness wanes over time, President Joe Biden’s administration announced that beginning the week of Monday, Sept. 20, booster shots would be made available for many Americans. Earlier story - COVID-19: US Expected To Announce Time Frame For All Americans To Get Booster Shots The Centers for Disease Control and Prevention (CDC) and US Food and Drug Administration (FDA) sa…

SHARE

by Zak Failla
Pelham, NY
News
COVID-19: New Study Reveals How Long Protection From Pfizer, Moderna Vaccines Could Last COVID-19: New Study Reveals How Long Protection From Pfizer, Moderna Vaccines Could Last
Covid-19: New Study Reveals How Long Protection From Pfizer, Moderna Vaccines Could Last Claims that booster shots could be required in several months for those receiving the Moderna and Pfizer COVID-19 vaccine may have been overblown, according to new reports. New findings in a study published this week showed that both COVID-19 vaccines have shown a “persistent” immune response to the virus that could potentially last years. The last looming question is how effective the vaccines are against variants of the virus, specifically the more transmissible Delta strain that has become dominant in the US and is present in 49 states. Related story - COVID-19: Parts Of US With Low Va…

SHARE

by Zak Failla
Pound Ridge, NY
News
COVID-19: New Studies Shed Light On Immunity For Those Who Were Vaccinated Or Had Virus COVID-19: New Studies Shed Light On Immunity For Those Who Were Vaccinated Or Had Virus
Covid-19: New Studies Shed Light On Immunity For Those Who Were Vaccinated Or Had Virus Brand-new studies are shedding light on how long immunity to COVID-19 lasts for those who have had the virus, been fully vaccinated, or both. Most who were infected with COVID and later immunized will not need booster shots, the studies show. Those who were vaccinated after never having the virus will likely need a booster shot as will some people who had COVID but did not have a strong immune response. One of the studies was published this week in the journal Nature. The other study was posted on the biology research site BioRxiv. Many who have been infected with COVID will likely make …

SHARE

by Joe Lombardi
Massapequa, NY
News
COVID-19: Pfizer, Moderna Release Clinical Trial Results On Response Against Virus Variants COVID-19: Pfizer, Moderna Release Clinical Trial Results On Response Against Virus Variants
Covid-19: Pfizer, Moderna Release Clinical Trial Results On Response Against Virus Variants Both Pfizer and Moderna - two of the three COVID-19 vaccines approved for distribution in the US - have seen promising results in combating variants of the virus in recent studies. This week, both pharmaceutical companies released results of clinical trials that show the vaccines are effective in combating COVID-19 variants, including the prominent strains from South Africa and Brazil. Moderna has been testing a 50-microgram dose of its vaccine in previously vaccinated people, which found the booster dose increased neutralizing antibody responses against the original virus as well as the va…

SHARE

by Zak Failla